Skip to main content
Caplight Logo









Testmate Health

Testmate Health

Private
LausanneHealthcare & Life Scienceshttps://www.testmatehealth.com/

Last Round

Seed

May 8, 2024

Total Funding Raised

$7.74M

Company Overview

Testmate Health is a medtech company that develops rapid at-home self-testing kits for sexually transmitted infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Biotechnology, Patient Engagement

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

at-home STI testSTI self-testmedtechrapid diagnosticsmolecular diagnosticshealthtechover-the-counter testOTC testsexual wellnessurine-based testmedical devicedigital health apptelemedicinedirect-to-consumerD2Cconnected diagnosticspublic health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Testmate Health Comparables

Compare Testmate Health with similar companies based on industry and business-model similarity.

Testmate Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Visby Medical
77%
Rapidemic
71%
myLAB Box
70%

Testmate Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 8, 2024
Pre SeedOct 27, 2021

Key People

Founding team and executive leadership

Kelly Lewis Brezoczky

Chief Operating Officer Interim CEO Advisor

Executive Team

Siew-Veena Sahi

CEO & Co-Founder

Founding Team

Testmate Health Investors

Notable investors and investment history

Testmate Health investors
InvestorRounds
Foreground CapitalSeed
GaingelsSeed
NEXT VENTŪRESPre Seed
DART VenturesSeed
Amboy Street VenturesSeed
The HelmSeed
RH CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 16, 2025

    Grew 30% QoQ from 10 to 13 employees.

  • Oct 30, 2024

    Monthly visitors increased 142% MoM.

Testmate Health Filings

Explore SEC and related filing metadata, where available.

Testmate Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Testmate Health's valuation, stock price, and market status.

Is Testmate Health a public or private company?

Testmate Health is a private company.

What is the current stock price of Testmate Health?

Testmate Health is a private company with no public stock price. No recent secondary market data is available.

How much is Testmate Health worth (valuation)?

Valuation information for Testmate Health is not publicly available.

Can I buy Testmate Health stock?

Testmate Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Testmate Health's last funding round?

Testmate Health's most recent funding round was Seed on May 8, 2024.

Who are the main investors in Testmate Health?

Key investors in Testmate Health include RH Capital, Rhia Ventures.

Will Testmate Health IPO soon?

No public IPO plans have been announced for Testmate Health.

How can I track Testmate Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Testmate Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLausanne
Employee Range10
Year Founded2020
Last FundingMay 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?